bioAffinity Technologies, Inc. (BIAFW) Return on equity 2022–2025
bioAffinity Technologies, Inc. (BIAFW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-204.9%FY2025 · since FY2022: -73.8% → -204.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -204.9% | +142.5 pp |
| FY2024 | -347.4% | -183.9 pp |
| FY2023 | -163.5% | -89.6 pp |
| FY2022 | -73.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Net marginBIAFW Gross profitBIAFW Gross marginBIAFW Operating incomeBIAFW Operating marginBIAFW Operating cash flowBIAFW Free cash flowBIAFW Capital expendituresBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →